One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …

Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …

Hepatocellular carcinoma (HCC) is the predominant primary liver cancer in many countries
and is the third most common cause of cancer-related death in the Asia-Pacific region. The …

Importance The presence of microvascular invasion (MVI) decreases surgical outcomes of
hepatocellular carcinoma (HCC). An accurate preoperative prediction of MVI can help …

Hepatitis B virus (HBV) can integrate into the human genome, contributing to genomic
instability and hepatocarcinogenesis. Here by conducting high-throughput viral integration …

Purpose To determine whether FOLFOX4 (infusional fluorouracil, leucovorin, and
oxaliplatin) administered as palliative chemotherapy to patients with advanced …

BACKGROUND & AIMS: The aim of this study was to compare the efficacy of radiofrequency
ablation (RFA) with surgical resection (RES) in the treatment of small hepatocellular …

The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
the burden of this devastating cancer is expected to increase further in coming years. The …

Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent
in many Asian countries and is the second most common cause of cancer‐related mortality …